BANK VONTOBEL/CALL/ELI LILLY & CO/400/0.1/21.06.24 Share Price

Warrant

DE000VU6BRT7

Delayed Deutsche Boerse AG 02:05:11 23/05/2024 pm IST
37.7 EUR +1.75% Intraday chart for BANK VONTOBEL/CALL/ELI LILLY & CO/400/0.1/21.06.24
Current month+2.97%
1 month+15.85%
Date Price Change
23/24/23 37.7 +1.75%
22/24/22 37.05 -1.72%
21/24/21 37.7 +6.20%
20/24/20 35.5 +2.96%
17/24/17 34.48 -1.34%

Delayed Quote Deutsche Boerse AG

Last update May 23, 2024 at 02:05 pm IST

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying ELI LILLY AND COMPANY
IssuerLogo Issuer Vontobel Vontobel
WKN VU6BRT
ISINDE000VU6BRT7
Date issued 17/04/2023
Strike 400 $
Maturity 21/06/2024 (30 Days)
Parity 10 : 1
Emission price 3.94
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 37.87
Lowest since issue 3.77
Delta0.97x
Omega 1.905
Premium0.77x
Gearing1.96x
Moneyness 2.007
Difference Strike -402.9 $
Difference Strike %-100.73%
Spread 0.2
Spread %0.53%
Intrinsic value 37.18

Company Profile

Eli Lilly and Company is one of the world's leading pharmaceutical groups. Net sales break down by therapeutic field as follows: - endocrinology (57.7%): products for treating osteoporosis, diabetes, and growth problems; - oncology (19.5%); - immunology diseases (11.1%); - neurology (8.4%): primarily drugs used in treating depression and schizophrenia; - other (3.3%). Net sales are distributed geographically as follows: the United States (63.9%), Europe (18.1%), Japan (4.9%), China (4.5%) and other (8.6%).
Sector
-
More about the company

Ratings for Eli Lilly and Company

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Eli Lilly and Company

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
802.9 USD
Average target price
850.4 USD
Spread / Average Target
+5.92%
Consensus